
Humana Inc HUM.N reported a quarterly adjusted loss of $2.16 per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -11 cents. The mean expectation of twenty four analysts for the quarter was for a loss of $2.16 per share. Wall Street expected results to range from $-2.52 to $-1.10 per share.
Revenue rose 13.5% to $29.20 billion from a year ago; analysts expected $28.84 billion.
Humana Inc's reported EPS for the quarter was a loss of $5.76.
The company reported a quarterly loss of $693 million.
Humana Inc shares had risen by 5.2% this quarter.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 1.8% in the last three months.
In the last 30 days, two analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 8 "strong buy" or "buy," 18 "hold" and 1 "sell" or "strong sell."
The average consensus recommendation for the managed healthcare peer group is also "hold"
Wall Street's median 12-month price target for Humana Inc is $289.00
This summary was machine generated from LSEG data February 11 at 12:30 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Dec. 31 2024 | -2.16 | -2.16 | Met |
Sep. 30 2024 | 3.40 | 4.16 | Beat |
Jun. 30 2024 | 5.85 | 6.96 | Beat |
Mar. 31 2024 | 6.12 | 7.23 | Beat |